HCPCS Level IIdrugActive
J9144
Daratumumab, hyaluronidase
BETOS: O1D
Effective: 2021-01-01
Description
Injection, daratumumab, 10 mg and hyaluronidase-fihj
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Darzalex Faspro
Manufacturer
Janssen Biotech, Inc.
HCPCS Dosage
10 MG
Billing Units
180.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.